Vaxcyte Inc.
PCVX | NASDAQ
$58.88
-$0.04 (-0.07%)
Sep 22, 2026, 12:28 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Cash & Equivalents | 173.96M | 387.88M | 397.45M | 834.66M | 68.99M | 386.2M |
Short-Term Investments | 1.39B | 1.36B | 682.78M | 96.72M | 176.99M | n/a |
Long-Term Investments | 883.13M | 1.39B | 162.68M | 26.55M | 27.12M | n/a |
Other Long-Term Assets | 508K | 65.68M | 38.67M | 5.43M | 4.96M | 550K |
Receivables | 46.56M | 20.66M | 3.61M | n/a | n/a | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 2.8M | 20.12M | 5.96M | n/a | n/a | n/a |
Total Current Assets | 1.63B | 1.79B | 1.1B | 942.56M | 256.35M | 389M |
Property-Plant & Equipment | 491.72M | 270.15M | 110.62M | 31.65M | 35.91M | 3.27M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 1.42B | 1.72B | 311.96M | 63.62M | 67.99M | 3.82M |
Total Assets | 3.05B | 3.51B | 1.41B | 1.01B | 324.34M | 392.83M |
Account Payables | 70.9M | 48.45M | 14.59M | 9.8M | 6.76M | 29.79M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | 6.12M | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities | 105.72M | 20.56M | 11.06M | 1.18M | 3.46M | 298K |
Total Current Liabilities | 205.75M | 140.18M | 145.34M | 40.53M | 28.72M | 46.86M |
Long-Term Debt | 111.36M | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | -111.26M | 100K | n/a | 9K | 96K | 122K |
Total Long-Term Liabilities | 154.7M | 65.32M | 22.11M | 12.04M | 11.6M | 122K |
Total Liabilities | 360.46M | 205.5M | 167.45M | 52.57M | 40.32M | 46.98M |
Total Debt | 228.84M | 71.11M | 29.22M | 17.94M | 16.78M | n/a |
Book Value | 2.69B | 3.31B | 1.24B | 953.61M | 284.02M | 345.84M |
Book Value Per Share | 19.73 | 27.10 | 12.77 | 14.70 | 5.47 | 11.71 |
Common Stock | 134K | 128K | 98K | 82K | 56K | 54K |
Retained Earnings | -2.15B | -1.39B | -924.39M | -522.13M | -298.64M | -198.56M |
Comprehensive Income | 1.59M | -3.87M | 179K | -361K | -241K | n/a |
Shareholders Equity | 2.69B | 3.31B | 1.24B | 953.61M | 284.02M | 345.84M |
Total Investments | 2.27B | 2.75B | 845.45M | 123.27M | 204.1M | n/a |
Add to Watchlist
Select watchlists to add or remove PCVX